Skip to content
An Initiative of AVAC
Search
Back to Country Data

Country Overview:
Sri Lanka

Global PrEP Tracker
Last Updated: 19 June 2025

Drug Registration Status

Approved
Pending
Not
Approved
Lenacapavir (LEN) for PrEP — Gilead
Data Not Available
Cabotegravir (CAB) for PrEP — ViiV
Not Approved
Dapivirine Vaginal Ring (DVR) — Pop Council
Not Approved
Oral PrEP TDF/FTC — Gilead (Truvada)
Approved
Oral PrEP TDF/xTC* - generic
Approved
Oral PrEP F/TAF — Gilead
Data Not Available
* TDF/xTC refers to tenofovir disoproxil fumarate (TDF) and either emtricitabine (FTC) or lamivudine (3TC)

Research, Demonstration and Implementation

Oral PrEP

N/A Completed Projects

Dapivirine Vaginal Ring

N/A Planned/Ongoing Projects

Injectable PrEP

N/A Planned/Ongoing Projects

Policy Frameworks

National HIV/STI Strategic Plan Sri Lanka, 2018-22

Est. Cumulative
Initiations:

Total PrEP: 269

Oral PrEP: 269

Dapivirine Vaginal Ring: N/A

Injectable PrEP: N/A

Featured Resources

Document

Sri Lanka National Communication Strategy, 2018-21

The plan in this document is to deploy mass media for comprehensive communication programs. This will be a key component in enabling the objective of ‘Ending AIDS by 2025’ in Sri Lanka, while breaking stigma and discrimination against those living with HIV/AIDS/STIs.
Document

Sri Lanka National M&E Plan, 2017-22

Monitoring and Evaluation of the response to HIV itself forms a vital component of the national response. Understanding the current epidemiological situation, emerging trends and the effectiveness of the response will lead to informed decision-making in policy and practice.
View All Resources